Trials / Completed
CompletedNCT00332046
fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder
A Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Parallel Group, fMRI Study Comparing BOLD Activation Patterns Before and After 12 Weeks of Treatment With Placebo, Comparator and GW679769 in Subjects With Social Anxiety Disorder (SAD).
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 57 (planned)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Evidence suggests the use of neuroimaging to detect therapeutic effects of anxiolytic treatment when appropriate cognitive-emotional tasks are use to activate the emotional brain neurocircuitry believed to be involved in the core symptoms of the disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GW679769 |
Timeline
- Start date
- 2006-01-01
- First posted
- 2006-06-01
- Last updated
- 2008-10-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00332046. Inclusion in this directory is not an endorsement.